Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TriNatal Rx is a prescription-strength prenatal multivitamin and mineral supplement developed and marketed by Trigen Laboratory. It is specifically formulated to meet the increased nutritional demands of women during pregnancy and the postpartum period, including lactation. The product typically contains a comprehensive blend of essential nutrients, most notably 1 mg of folic acid to reduce the risk of neural tube defects and carbonyl iron to support maternal blood volume expansion and fetal oxygenation. Other components include vitamins A, C, D3, E, and the B-complex, along with minerals like calcium, zinc, and copper. As a regulated pharmaceutical product, it is used to prevent or treat vitamin and mineral deficiencies that cannot be managed by diet alone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TriNatal Rx.